Elliot Sigal, Director at Spark Therapeutics, Inc. (ONCE), bought 36,559 shares at $23.00 ($115K) on 2015-02-04, disclosed to the SEC on 2015-02-06.
Open-market purchase of $115k ONCE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 31,559 | $0 | 0.0% |
| 2 | $23.00 | 5,000 | $115K | 100.0% |
| Total | $3.15 avg | 36,559 | $115K | 100% |
| Filing → |
| BMY | SELL | 2013-06-05 | $4.0M | — | Filing → |
| BMY | SELL | 2013-05-31 | $6.8M | — | Filing → |
| BMY | SELL | 2013-05-01 | $19.3M | — | Filing → |